Brief: Skye Bioscience Says Kaitlyn Arsenault To Step Down As CFO Effective Feb 20
20/02/2026 22:35
Feb 20 (Reuters) - Skye Bioscience Inc SKYE.O: SKYE BIOSCIENCE INC - KAITLYN ARSENAULT TO STEP DOWN AS CFO EFFECTIVE FEB 20, 2026 - SEC FILING Source text: [ID:n0001628280-26-010186] Further company coverage: SKYE.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Skye Bioscience
See all newsBrief: Skye Announces Cohort Review Committee Approved Opening Of Cohort 2 Based On Favorable Safety Data From First Four Participants Treated In Cohort 1
U.S. RESEARCH ROUNDUP-Accuray, Aevex, Zoetis
U.S. STOCKS ON THE MOVE-Tesla, Blue Owl, Ford
U.S. STOCKS ON THE MOVE-Energy firms, Estee Lauder, HMH Holding
Skye Bioscience rises as it begins testing higher doses of obesity drug